Sutro Biopharma, Arvinas Are Latest to Tee Up Biotech IPOs

The biotech IPO train is rolling on without slowing as we head into a holiday weekend. The latest to lay the groundwork to go public are Sutro Biopharma and Arvinas, which both want Wall Street’s help to back human trials of experimental cancer drugs.